Seven Seas Exporter

Lenvenib 4mg Capsule can be taken with or without food, but try to have it at the same time every day to get the most benefits. Your doctor will determine the right dose and how often you should take it. This will depend on what you are being treated for. The dosage may change over time. You should take it exactly as your doctor has advised. Taking it the wrong way or taking too much can cause very serious side effects.

Common side effects of this medicine include high blood pressure, bleeding, and diarrhea. It might also cause severe headaches and loss of appetite. If any of these side effects persist or worsen, consult your doctor. They may be able to suggest ways to manage the side effects.

Before taking Lenvenib 4mg Capsule, tell your doctor if you have heart disease, liver, or kidney problems, or are taking any medicines to treat infections. Many other medicines can affect or be affected by this medicine, so let your doctor know about all the medicines you are taking. Pregnant and breastfeeding women should consult their doctors before starting this medicine, as it may cause harm to the developing baby.

• Buy Poxet  , which is Men’s Health medication, and it contains Dapoxetine. Poxet  is a premature ejaculation pill. Dapoxetine 30,60,90 mg passes correct nerve messages that are directly related to increasing ejaculation time.
• The active ingredient in Poxet 30,60,90 is Dapoxetine which is considered a selective serotonin reuptake inhibitor type of medicine.   Dapoxetine    works on increasing the activity of serotonin in the nervous system and delaying the nerve sensation that results in ejaculation.

Terol LA-2(Tolterodine ) is an antimuscarinic drug that is used to treat urinary incontinence.

Tolterodine is a competitive muscarinic receptor antagonist with actions similar to atropine. It is used in the management of urge urinary incontinence, urgency and frequency.

Dinex EC is a nucleoside reverse transcriptase inhibitor that inhibits DNA synthesis of retroviruses by competitive inhibition of reverse transcriptase and incorporation into viral DNA.
Absorption: Rapidly hydrolysed in the gastric acid. Bioavailability ranges from 20-40%.

Specification:

• Multiple myeloma
• Mantle-cell lymphoma

• Low blood platelets
• Fatigue
• Peripheral neuropathy (tingling and numbness of feet and hand)
• Psychiatric disturbances
• Nausea
• Vomiting
• Loss of appetite
• Fever
• Anemia (low number of red blood cells)
• Diarrhea
• Decreased appetite
• Decreased white blood cell count (neutrophils)
• Constipation

Iritero is an injectable formulation of Irinotecan, a chemotherapy medication used primarily in the treatment of various cancers, especially colorectal cancer. It is often utilized in combination with other chemotherapy agents to enhance its efficacy.

Iritero is indicated for:

• Colorectal Cancer: Treatment of metastatic colorectal cancer, typically in combination with fluorouracil and leucovorin.
• Small Cell Lung Cancer: Used in patients with extensive-stage small cell lung cancer.

Irinotecan works as a topoisomerase I inhibitor. It interferes with DNA replication and repair, leading to the accumulation of DNA breaks and ultimately cell death, particularly in rapidly dividing cancer cells.

• Standard Dosage: The recommended dosage of Iritero is 180 mg/m², administered as an intravenous infusion every two weeks, depending on the treatment protocol and patient tolerance.
• Administration: Administer via slow intravenous infusion over 90 minutes. Dosage adjustments may be necessary based on individual patient factors, including side effects and response to treatment.

Iritero is contraindicated in:

• Hypersensitivity: Known allergy to irinotecan or any components of the formulation.
• Severe Bone Marrow Suppression: Patients with significant myelosuppression should not receive this medication.

• Myelosuppression: Regular monitoring of blood counts is essential due to the risk of neutropenia and thrombocytopenia.
• Diarrhea: Severe diarrhea can occur and may require treatment with loperamide; monitor for signs of dehydration.
• Hepatic Impairment: Dose adjustments may be necessary in patients with liver dysfunction.

Common side effects may include:

• Nausea and vomiting
• Diarrhea
• Fatigue
• Abdominal pain
• Hair loss (alopecia)

Serious side effects can include:

• Severe myelosuppression (neutropenia, anemia)
• Dehydration due to diarrhea
• Infection risk due to immunosuppression

Iritero may interact with other medications, particularly those that affect liver enzymes or have myelosuppressive effects. Patients should inform their healthcare provider about all medications they are taking.

Store Iritero (Irinotecan 100 mg Injection) at room temperature, protected from light. Do not freeze.

• Educate patients on the importance of hydration and managing diarrhea.
• Discuss the need for regular blood tests to monitor for myelosuppression.
• Advise patients to report any unusual symptoms, such as fever or persistent diarrhea.

Iritero (Irinotecan 100 mg Injection) is a key component in the treatment of certain cancers, particularly colorectal cancer, providing a vital option for patients. Proper administration and monitoring are crucial for maximizing therapeutic benefits while minimizing risks.